XML 28 R9.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Investments and Other Assets | 6 Months Ended
--- | ---
Jun. 30, 2017
Investments, All Other Investments [Abstract] |
Investments and other assets | Investments and other assets Our investments and other assets consisted of the following as of June 30, 2017, and December 31, 2016 (in thousands):
| June 30, 2017 |  | Dec. 31, 2016
|  |  | (recast)
Cash value life insurance | $ | 63,701 |  |  | $ | 64,134 |
Deferred compensation investments | 28,667 |  |  | 23,715 |
Equity method investments | 15,831 |  |  | 18,016 |
Available for sale investment | — |  |  | 16,744 |
Deferred debt issuance cost | 7,968 |  |  | 9,856 |
Other long term assets | 41,498 |  |  | 48,151 |
Total | $ | 157,665 |  |  | $ | 180,616 |
Deferred compensation investments: Employee compensation-related investments consist of debt and equity securities which are classified as trading securities and fund our deferred compensation plan liabilities. Equity method investments: Investments over which we have the ability to exercise significant influence but do not control, are accounted for under the equity method of accounting. Significant influence typically exists when we own between 20% and 50% of the voting interests in a corporation, own more than a minimal investment in a limited liability company, or hold substantial management rights in the investee. Under this method of accounting, our share of the net earnings or losses of the investee is included in non-operating income on our Consolidated Statements of Income. We evaluate our equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investments may be impaired. If a decline in the value of an equity method investment is determined to be other than temporary, a loss is recorded in earnings in the current period. Certain differences exist between our investment carrying value and the underlying equity of the investee companies, principally due to fair value measurement at the date of investment acquisition and due to impairment charges we recorded for certain investments. Available for sale investment: Our investment in Gannett Co., Inc., common stock, previously classified as a noncurrent asset, was reclassified to a current asset in the second quarter of 2017 due to our intent to sell the investment by the end of 2017. Other long term assets: During the quarter and six months ended June 30, 2017, we recognized a $5.8 million loss associated with a write-off of a note receivable from one of our equity method investments. This loss is reflected in Other non-operating items, in the accompanying Consolidated Statements of Income. The loss was a result of a decision made during the second quarter by the investee’s board of directors to discontinue the business, and the investee not having sufficient funds to repay the full note at that time. Cost method investments: The carrying value of cost method investments was $15.1 million of June 30, 2017 and $14.8 million as of December 31, 2016, and is included within other long term assets in the table above.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments and other noncurrent assets. + References No definition available. + Details
Name: | us-gaap_InvestmentsAndOtherNoncurrentAssetsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration